Versor Investments LP Makes New $522,000 Investment in Amdocs Limited $DOX

Key Points

• Versor Investments LP has made a new investment of approximately $522,000 in Amdocs Limited, acquiring 5,700 shares during the first quarter.
• Amdocs recently had its rating upgraded from "hold" to "buy" by Wall Street Zen, with an average target price set at $105.33.
• The company reported earnings of $1.72 per share, exceeding analysts' expectations, with a quarterly revenue of $1.14 billion.

Versor Investments LP bought a new position in shares of Amdocs Limited (NASDAQ:DOX - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 5,700 shares of the technology company's stock, valued at approximately $522,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Farther Finance Advisors LLC grew its stake in shares of Amdocs by 17.5% in the first quarter. Farther Finance Advisors LLC now owns 988 shares of the technology company's stock worth $90,000 after purchasing an additional 147 shares during the last quarter. Corbyn Investment Management Inc. MD grew its stake in shares of Amdocs by 0.4% in the first quarter. Corbyn Investment Management Inc. MD now owns 38,866 shares of the technology company's stock worth $3,556,000 after purchasing an additional 152 shares during the last quarter. PNC Financial Services Group Inc. grew its stake in shares of Amdocs by 3.5% in the first quarter. PNC Financial Services Group Inc. now owns 5,247 shares of the technology company's stock worth $480,000 after purchasing an additional 177 shares during the last quarter. Denali Advisors LLC grew its stake in shares of Amdocs by 3.6% in the first quarter. Denali Advisors LLC now owns 5,810 shares of the technology company's stock worth $532,000 after purchasing an additional 200 shares during the last quarter. Finally, Tower Research Capital LLC TRC grew its stake in shares of Amdocs by 55.0% in the fourth quarter. Tower Research Capital LLC TRC now owns 586 shares of the technology company's stock worth $50,000 after purchasing an additional 208 shares during the last quarter. Institutional investors own 92.02% of the company's stock.

Amdocs Stock Down 1.2%

Shares of NASDAQ:DOX traded down $1.07 during midday trading on Monday, hitting $87.20. 548,005 shares of the company's stock were exchanged, compared to its average volume of 884,137. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.22 and a quick ratio of 1.22. The stock has a 50 day moving average price of $89.02 and a 200-day moving average price of $88.80. The company has a market cap of $9.84 billion, a PE ratio of 17.69, a price-to-earnings-growth ratio of 1.61 and a beta of 0.51. Amdocs Limited has a 12 month low of $78.61 and a 12 month high of $95.41.

Amdocs (NASDAQ:DOX - Get Free Report) last posted its earnings results on Wednesday, August 6th. The technology company reported $1.72 EPS for the quarter, topping the consensus estimate of $1.71 by $0.01. The company had revenue of $1.14 billion during the quarter, compared to the consensus estimate of $1.13 billion. Amdocs had a net margin of 11.94% and a return on equity of 19.66%. The firm's revenue for the quarter was down 8.4% on a year-over-year basis. During the same period in the previous year, the firm posted $1.62 earnings per share. On average, sell-side analysts anticipate that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be given a dividend of $0.527 per share. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $2.11 annualized dividend and a dividend yield of 2.4%. Amdocs's payout ratio is presently 42.80%.

Wall Street Analyst Weigh In

Several research firms recently issued reports on DOX. Wolfe Research began coverage on shares of Amdocs in a report on Tuesday, July 8th. They issued an "outperform" rating on the stock. Wall Street Zen upgraded shares of Amdocs from a "hold" rating to a "buy" rating in a report on Sunday, August 10th. Four analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus target price of $105.33.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.